Matches in Wikidata for { <http://www.wikidata.org/entity/Q63808130> ?p ?o ?g. }
- Q63808130 description "clinical trial" @default.
- Q63808130 description "ensayu clínicu" @default.
- Q63808130 description "klinisch onderzoek" @default.
- Q63808130 description "клінічне випробування" @default.
- Q63808130 name "Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer" @default.
- Q63808130 type Item @default.
- Q63808130 label "Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer" @default.
- Q63808130 prefLabel "Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer" @default.
- Q63808130 P1050 Q63808130-F4ACE202-6AE7-4573-90EC-A8E38E637A39 @default.
- Q63808130 P1132 Q63808130-4A0067F1-DF73-49D8-9693-C478980F2D82 @default.
- Q63808130 P1476 Q63808130-07A51654-F3F3-45CD-9C97-059C8228BD48 @default.
- Q63808130 P17 Q63808130-8F131065-34E5-4423-8D60-7220A6199AD5 @default.
- Q63808130 P17 Q63808130-A47B3058-0DEA-4C14-9204-7AAC1C32992E @default.
- Q63808130 P17 Q63808130-AA848BC2-87EE-4682-BB87-91641FB8959D @default.
- Q63808130 P2899 Q63808130-F678AEEA-2371-43A1-BB36-7C6DD95D5F3B @default.
- Q63808130 P3098 Q63808130-B42097A0-D3F1-4849-AA16-ABFB4EB0C181 @default.
- Q63808130 P31 Q63808130-2C3E9436-660C-4310-AB07-5D5EB2445859 @default.
- Q63808130 P4844 Q63808130-56DED198-3F6B-42B9-9F59-B4A4DE17E13C @default.
- Q63808130 P4844 Q63808130-872721D1-4BA7-4009-9428-0A8BA0BF794B @default.
- Q63808130 P4844 Q63808130-8A0BA3FD-D768-4431-BFBF-25DB75FA5551 @default.
- Q63808130 P4844 Q63808130-A4913945-1D39-4E5B-862C-342485B6EB6B @default.
- Q63808130 P4844 Q63808130-D858099B-5EA8-487C-8E91-1CDE51DFF845 @default.
- Q63808130 P4844 Q63808130-DBA16B1C-F323-4316-A6DD-11C804B3314B @default.
- Q63808130 P580 Q63808130-2CE10D1D-D1E3-4373-961F-48D5D78A75E1 @default.
- Q63808130 P582 Q63808130-9DE0E35A-D21C-465A-BEB4-9AB9BD3CBA80 @default.
- Q63808130 P6099 Q63808130-58CE6678-1400-4CB6-8437-2BC648BEC40A @default.
- Q63808130 P6153 Q63808130-05E858F2-6294-46D1-8386-47C03B55E12A @default.
- Q63808130 P6153 Q63808130-0883E2D1-938C-42FD-A75F-597F1424F1E7 @default.
- Q63808130 P6153 Q63808130-08A71FF4-CB40-4096-AC4C-4A3B583E7863 @default.
- Q63808130 P6153 Q63808130-0DD6477B-0591-4171-8594-05A03D15E25A @default.
- Q63808130 P6153 Q63808130-0EA289E4-DF0A-4EC5-BE4A-502B1096A640 @default.
- Q63808130 P6153 Q63808130-0FC0E7C5-74D5-4E3C-B9AA-5DD1D60CCCEB @default.
- Q63808130 P6153 Q63808130-0FF6F91C-A7C0-4B19-B912-152EEE74042E @default.
- Q63808130 P6153 Q63808130-10ABCC5D-B685-4FFE-AD6D-3282C1385E38 @default.
- Q63808130 P6153 Q63808130-1135E5E5-BC66-45E3-B947-FC6FBAEE692D @default.
- Q63808130 P6153 Q63808130-167A241E-6F92-45E2-9608-B1169E626E41 @default.
- Q63808130 P6153 Q63808130-196DBAB4-8B8E-472E-8246-1DA96617C595 @default.
- Q63808130 P6153 Q63808130-266A02E3-2C7D-418B-BB2B-8F3ABB3EA6CF @default.
- Q63808130 P6153 Q63808130-35222FAF-1280-4FFF-9DCD-1F43C70223E0 @default.
- Q63808130 P6153 Q63808130-3E9D4D98-922B-4165-B53B-7DE05EE81274 @default.
- Q63808130 P6153 Q63808130-3F28F926-E5BB-4DED-9555-E2DEF3761C71 @default.
- Q63808130 P6153 Q63808130-44728598-9B98-4C65-92B1-C1A15D5A67B9 @default.
- Q63808130 P6153 Q63808130-474D0173-0E2C-4EB3-B2ED-5812C0AFBC35 @default.
- Q63808130 P6153 Q63808130-479B8505-F23B-4506-BE5A-4C6A8A9595E3 @default.
- Q63808130 P6153 Q63808130-5D4D1251-3F42-4108-B883-951DE7E50603 @default.
- Q63808130 P6153 Q63808130-61A5AD53-FAFF-4140-AD33-D69A6867F7CB @default.
- Q63808130 P6153 Q63808130-69C0FB08-4009-4782-89E4-FB48B2BE14C8 @default.
- Q63808130 P6153 Q63808130-6B327E74-7BDC-424C-B5C4-9FE7F9FC3B3F @default.
- Q63808130 P6153 Q63808130-6B80C39C-59F2-442C-82E5-BC3817A3297C @default.
- Q63808130 P6153 Q63808130-7A83CAED-71E7-4F81-ACF0-015634F6EB2C @default.
- Q63808130 P6153 Q63808130-81332A44-17BE-4D8C-95DE-58CC03375EE8 @default.
- Q63808130 P6153 Q63808130-87C78B03-65EE-435D-8A48-296218246B4E @default.
- Q63808130 P6153 Q63808130-8AB1F7E5-97DF-44E4-AB90-A5C193C3529B @default.
- Q63808130 P6153 Q63808130-8B9C6DA1-626B-4956-A585-BF7BF6960E64 @default.
- Q63808130 P6153 Q63808130-9BD62CB7-736C-40E0-B784-035421F4508F @default.
- Q63808130 P6153 Q63808130-A37C9B48-A072-45A3-8E44-0A192FAFE213 @default.
- Q63808130 P6153 Q63808130-A41B26B0-0484-4762-9483-A524420CCF54 @default.
- Q63808130 P6153 Q63808130-AA4D1B90-18D8-4EF0-9EF8-FF72316F6489 @default.
- Q63808130 P6153 Q63808130-AB45EBF3-1895-4316-8CCE-F92FACB1594A @default.
- Q63808130 P6153 Q63808130-AC2F4621-A55E-46EB-856D-5206B25D1138 @default.
- Q63808130 P6153 Q63808130-AC4B0D1A-00F1-4429-B473-A6F5D0399F9A @default.
- Q63808130 P6153 Q63808130-B68E11E4-71F6-484F-8A0D-4F788C801793 @default.
- Q63808130 P6153 Q63808130-BD755807-821B-4A42-97F7-26082C72DA17 @default.
- Q63808130 P6153 Q63808130-C28AB281-C1F9-4996-9D54-5230AFFA5FEF @default.
- Q63808130 P6153 Q63808130-D0D0CAA8-E838-4244-9CA7-BECA3EEE6570 @default.
- Q63808130 P6153 Q63808130-D827F7E9-A307-436F-8469-949F45E9597E @default.
- Q63808130 P6153 Q63808130-DE612954-54C8-4298-B993-06849625A8CC @default.
- Q63808130 P6153 Q63808130-E4138657-14EB-4C24-964B-0A596769B69A @default.
- Q63808130 P6153 Q63808130-E801A1B5-7CF5-4502-BE85-F1DAEA412578 @default.
- Q63808130 P6153 Q63808130-E89DCB71-4B22-4F59-830B-2B44C237D965 @default.
- Q63808130 P6153 Q63808130-E9894C5A-A26E-4BD9-87AA-9BAA4A9B1D37 @default.
- Q63808130 P6153 Q63808130-EC11F8EE-BC0F-4F6F-84EE-E3FF175482C7 @default.
- Q63808130 P6153 Q63808130-F8B12576-49A6-48C4-9518-A8423C6A7E0E @default.
- Q63808130 P6153 Q63808130-F95F0D16-8B7A-4A6E-9079-0ECA52F434F4 @default.
- Q63808130 P6153 Q63808130-FEDFCDEE-6CD0-4990-B3D7-A127A5146E0F @default.
- Q63808130 P8363 Q63808130-8BDF8208-A572-4D49-A452-A61F85C7C9C3 @default.
- Q63808130 P1050 Q356033 @default.
- Q63808130 P1132 "+3436" @default.
- Q63808130 P1476 "Phase III Trial of Doxorubicin and Cyclophosphamide (AC) Followed by Weekly Paclitaxel With or Without Trastuzumab as Adjuvant Treatment for Women With HER-2 Over-Expressing or Amplified Node Positive or High-Risk Node Negative Breast Cancer" @default.
- Q63808130 P17 Q16 @default.
- Q63808130 P17 Q258 @default.
- Q63808130 P17 Q419 @default.
- Q63808130 P2899 "+18" @default.
- Q63808130 P3098 "NCT00005970" @default.
- Q63808130 P31 Q30612 @default.
- Q63808130 P4844 Q18936 @default.
- Q63808130 P4844 Q29004943 @default.
- Q63808130 P4844 Q408524 @default.
- Q63808130 P4844 Q412178 @default.
- Q63808130 P4844 Q423762 @default.
- Q63808130 P4844 Q50429626 @default.
- Q63808130 P580 "2000-05-19T00:00:00Z" @default.
- Q63808130 P582 "2005-04-25T00:00:00Z" @default.
- Q63808130 P6099 Q42824827 @default.
- Q63808130 P6153 Q1047060 @default.
- Q63808130 P6153 Q1048851 @default.
- Q63808130 P6153 Q1061104 @default.
- Q63808130 P6153 Q1130172 @default.
- Q63808130 P6153 Q1150105 @default.
- Q63808130 P6153 Q1159198 @default.